NutraLife BioSciences, Inc.
NLBS
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -1.18M | -900.40K | -1.08M | -1.79M | -688.30K |
| Total Depreciation and Amortization | 110.40K | 110.90K | 124.10K | 76.20K | 87.20K |
| Total Amortization of Deferred Charges | 47.70K | 53.00K | 100.20K | 140.90K | 116.80K |
| Total Other Non-Cash Items | 571.30K | 355.50K | 452.30K | 967.30K | 120.00K |
| Change in Net Operating Assets | 8.50K | 132.90K | -45.60K | 1.08M | 34.40K |
| Cash from Operations | -440.00K | -248.20K | -453.20K | 471.90K | -329.80K |
| Capital Expenditure | -3.20K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -500.00K | 0.00 | -725.00K | -675.00K | -- |
| Cash from Investing | -503.20K | 0.00 | -725.00K | -675.00K | -- |
| Total Debt Issued | -884.70K | 1.27M | 65.00K | 212.60K | 297.50K |
| Total Debt Repaid | -152.20K | -52.00K | -49.30K | -4.20K | -4.80K |
| Issuance of Common Stock | 0.00 | 0.00 | 110.00K | 0.00 | 155.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.36M | -975.00K | 975.00K | -- | -- |
| Cash from Financing | 1.32M | 241.70K | 1.10M | 208.40K | 447.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 379.90K | -6.50K | -77.50K | 5.30K | 117.80K |
